Patent · US Active

Dual specific binding proteins directed against IL-13 and IL-17

US9120870B2 · kind B2 · utility

6Cited by
133References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2012
Grant dateSep 1, 2015
Priority date—
Expiry dateApr 22, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/5437
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Engineered multivalent and multispecific binding proteins that bind IL-13 and/or IL-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.